Grand River Aseptic Manufacturing new state-of-the-art facilities for fill-finish biologics capacity

Grand River Aseptic Manufacturing (GRAM), as the name suggests, is a leading sterile injectable drug manufacturer based in Grand Rapids, Michigan. Following significant investments in state-of-the-art facilities and equipment, GRAM has capacity for fill-finish biologics, small molecules, and vaccines.

Ahead of CDMO Live, we had the opportunity to sit down with David Powell, Vice President of Business Development at GRAM.

“We strive to have the latest manufacturing technology. All our equipment is always cutting-edge. But at the same time, as a good old Mid-west company, customer focus, authenticity, and transparency are the hallmarks of who we are.” say David

During the COVID-19 pandemic, GRAM helped manufacture the vaccine. “We pivoted and quickly invested in more capacity. Now, post-COVID, we have a significant amount of capacity available to our customers, with a total of three fill lines and a fourth on the way,” David explained.

With newer capabilities and facilities, GRAM has pivoted to specialize in biologics fill-finish.

“That is where our sweet spot is. We’re not into drug substance, we’re not in oral solids, we are really just focused on fill-finish and helping our customers, large or small, take their products through and get it to market.”

GRAM have announced plans for a third manufacturing facility focused on syringe and cartridge filling to complement existing capabilities.

“We’re leaving plenty of space to also get into more downstream auto injector and other device manufacturers assembly for our syringe and cartridge customers. We realize we need to continue to expand in there to match the market demand.”

• Read the full article on PharmaSource